Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

PLoS One · 2015 · PMC4492580 · PMID 26148007

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < .0001actually significant

The time to first parasitemia is shown in a plot of the Kaplan Meier survival estimate in Fig 2 , indicating no significant difference between ARR and RRR groups by blood smear ( P = .46) and by PCR ( P = .41) in contrast to highly significant differences between ARR and RRR compared to infectivity controls ( P < .0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.